The Discounted Cash Flow (DCF) valuation of ADMA Biologics Inc (ADMA) is 26.35 USD. With the latest stock price at 9.19 USD, the upside of ADMA Biologics Inc based on DCF is 186.7%.
Based on the latest price of 9.19 USD and our DCF valuation, ADMA Biologics Inc (ADMA) is a buy. buying ADMA stocks now will result in a potential gain of 186.7%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 9.0% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 15.88 - 86.62 | 26.35 |
| Upside | 72.8% - 842.5% | 186.7% |